Cargando…

Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin

BACKGROUND: The aim of this study was to evaluate the clinically significant predictors of hepatocellular carcinoma (HCC) development among hepatitis C virus (HCV) cirrhotic patients receiving combination therapy. PATIENTS AND METHODS: One hundred and five compensated cirrhosis patients who received...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Khai-Jing, Tseng, Chih-Wei, Chang, Ting-Tsung, Tzeng, Shinn-Jia, Hsieh, Yu-Hsi, Hung, Tsung-Hsing, Huang, Hsiang-Ting, Wu, Shu-Fen, Tseng, Kuo-Chih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976814/ https://www.ncbi.nlm.nih.gov/pubmed/27536084 http://dx.doi.org/10.2147/CIA.S108589

Ejemplares similares

Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C
por: Tseng, Chih-Wei, et al.
Publicado: (2016)

Peginterferon Alfa-2a Is Associated with Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients with Sustained Virologic Response
por: Tseng, Chih-Wei, et al.
Publicado: (2014)

Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
por: Chak, Eric, et al.
Publicado: (2010)

Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy
por: Hsu, Ching-Sheng, et al.
Publicado: (2016)

Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan
por: Chang, Yu-Kang, et al.
Publicado: (2019)

Peripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patients
por: Lee, Chuan-Mo, et al.
Publicado: (2016)

Favorable Outcomes of Chinese HCV-Related Cirrhotic Patients with Sustained Virological Response after Pegylated Interferon Plus Ribavirin Treatment
por: Zhang, Geng-lin, et al.
Publicado: (2017)

Associations of alanine aminotransferase/aspartate aminotransferase with insulin resistance and β-cell function in women
por: Minato-Inokawa, Satomi, et al.
Publicado: (2023)

No Mortality Difference Following Treatment with Terlipressin or Somatostatin in Cirrhotic Patients with Gastric Variceal Hemorrhage
por: Hung, Tsung-Hsing, et al.
Publicado: (2016)

Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study
por: Kovari, Helen, et al.
Publicado: (2015)

Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy
por: Chopra, Amit, et al.
Publicado: (2015)

Aspartate aminotransferase/alanine aminotransferase ratio and subsequent cancer development
por: Kobayashi, Daiki, et al.
Publicado: (2021)

Circulating sCD14 Is Associated with Virological Response to Pegylated-Interferon-Alpha/Ribavirin Treatment in HIV/HCV Co-Infected Patients
por: Marchetti, Giulia, et al.
Publicado: (2012)

The Association of Aspartate Aminotransferase/Alanine Aminotransferase Ratio with Diabetic Nephropathy in Patients with Type 2 Diabetes
por: Xu, Jing, et al.
Publicado: (2021)

Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure
por: Maeda, Daichi, et al.
Publicado: (2021)

Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis
por: Frager, Shalom Z., et al.
Publicado: (2020)

Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin
por: Choi, Sang Bun, et al.
Publicado: (2011)

Predictors of Virological Response to a Combination Therapy with Pegylated Interferon Plus Ribavirin Including Virus and Host Factors
por: Izumi, Namiki, et al.
Publicado: (2010)

High mortality of pneumonia in cirrhotic patients with ascites
por: Hung, Tsung-Hsing, et al.
Publicado: (2013)

Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients With Hepatic Encephalopathy: A Population-Based 3-Year Follow-Up Study
por: Hung, Tsung-Hsing, et al.
Publicado: (2014)

No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment
por: Hung, Tsung-Hsing, et al.
Publicado: (2016)

The Effect of the First Spontaneous Bacterial Peritonitis Event on the Mortality of Cirrhotic Patients with Ascites: A Nationwide Population-Based Study in Taiwan
por: Hung, Tsung-Hsing, et al.
Publicado: (2016)

The long-term outcomes of cirrhotic patients with pleural effusion
por: Hung, Tsung-Hsing, et al.
Publicado: (2018)

Endoscopic papillary balloon dilation decreases the risk of bleeding in cirrhotic patients compared with endoscopic biliary sphincterotomy: A national population-based study
por: Hung, Tsung-Hsing, et al.
Publicado: (2019)

Isolated elevated aspartate aminotransferase in an asymptomatic woman due to macro-aspartate aminotransferase: A case report
por: Zhan, Meng-Ru, et al.
Publicado: (2019)

Aspartate aminotransferase-to-platelet ratio index can predict the outcome in patients with stable decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2023)

High Mortality of Cirrhotic Patients With End-Stage Renal Disease
por: Hung, Tsung-Hsing, et al.
Publicado: (2016)

Aspartate Aminotransferase and Alanine Aminotransferase Detection on Paper-Based Analytical Devices with Inkjet Printer-Sprayed Reagents
por: Wang, Hsiang-Li, et al.
Publicado: (2016)

Targeting aspartate aminotransferase in breast cancer
por: Thornburg, Joshua Marshall, et al.
Publicado: (2008)

The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment
por: Weng, Stephen F, et al.
Publicado: (2015)

Remdesivir: Elevated aspartate aminotransferase and alanine aminotransferase levels: case report
Publicado: (2022)

Prediction of sustained virologic responses to combination therapy of pegylated interferon-α and ribavirin in patients with chronic hepatitis C infection
por: Ismail, Mona H.
Publicado: (2013)

Analysis of Different Types of Interferon-Associated Retinopathy in Patients with Chronic Hepatitis C Virus Infection Treated with Pegylated Interferon Plus Ribavirin
por: Wu, Chia-Min, et al.
Publicado: (2021)

IMPACT OF THE PEGYLATED-INTERFERON AND RIBAVIRIN THERAPY ON THE TREATMENT-RELATED MORTALITY OF PATIENTS WITH CIRRHOSIS DUE TO HEPATITIS C VIRUS
por: DRESCH, Kelly Fernanda Nomura, et al.
Publicado: (2016)

Aspartate Aminotransferase (AST/GOT) and Alanine Aminotransferase (ALT/GPT) Detection Techniques
por: Huang, Xing-Jiu, et al.
Publicado: (2006)

Macro-aspartate aminotransferase in a healthy woman
por: Lorubbio, Maria, et al.
Publicado: (2020)

Importance Of Laboratory Detection Of Macro-Aspartate Aminotransferase
por: Ono, Shiro, et al.
Publicado: (2019)

The Association between Anthropometry Indices and Serum Concentrations of Gamma-Glutamyl Transferase, Alkaline Phosphatase, Alanine Aminotransferase, and Aspartate Aminotransferase
por: Sobhani, Sahar, et al.
Publicado: (2021)

Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan
por: Hung, Tsung-Hsing, et al.
Publicado: (2017)

Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapy
por: Hu, Ching-Chih, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_95bnclmv77u9tqj017upclrrdj